Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 26, 1996 - Issue 1
10
Views
12
CrossRef citations to date
0
Altmetric
Research Article

Immunohistochemical assessment of human microsomal epoxide hydrolase in primary and secondary liver neoplasm: a quantitative approach

, , , , &
Pages 107-116 | Published online: 17 Nov 2010

References

  • ALTMANN, H. W., 1994, Hepatic neoformations. Pathology Research Practicals, 190, 513–577.
  • ALVES, C., VON-DIPPE, P., Amout, M., and LEVY, D., 1993, Bile acid transport into hepatocyte smooth endoplasmic reticulum vesicles is mediated by microsomal epoxide hydrolase, a membrane protein exhibiting two distinct topological orientations. Journal of Biological Chemistry, 268, 20148–20155.
  • BARON, J., REDICK, J. A., and GUENGERICH, F. P., 1980, Immunohistochemical localization of epoxide hydratase in rat liver. Life Sciences, 26, 489–493.
  • BEAUNE, P., KREMERS, F., LETAWE-GOUJON, F., and GIELEN, J. E., 1985, Monoclonal antibodies against human liver cytochrome P-450. Biochemical Pharmacology, 34, 3547–3552.
  • BEETHAM, J. K., GRANT, D., ARAND, M., GARBARINO, J., KIYOSUE, T., PINOT, F., DESCH, F., BALKNAP, W. R., SHINOZAKI, K., and HAMMOCK, B. D., 1995, Gene evolution of epoxide hydrolases and recommended nomenclature. DNA Cell Biology, 14, 61–71.
  • BEETHAM, J. K., TIAN, T., and HAMMOCK, B. D., 1993, CDNA cloning and expression of a soluble epoxide hydrolase from human liver. Archives in Biochemistry and Biophysics, 305, 197–201.
  • BENTLEY, P., WAECHTER, F., OESCH, F., and STAUBLI, W., 1979, Immunochemical localization of epoxide hydratase in rat liver: effects of 2-acetylaminofluorene. Biochemical and Biophysical Research Communications, 91, 1101–1108.
  • BOHRER, M. H., HASTKA, J., and VERBECICE, C. S., 1992, Differentialdiagnose von hepatischen Tumormanifestationen in der bioptischen Diagnostik. Immunhistochemische Abgrenzung von Leberzellkarzinomen. Tumordiagn Therapie, 13, 187–189.
  • BUCHMANN, A., KUHLMANN, W. D., SCHWARZ, M., KUNZ, H. W., WOLF, C. R., MOLL, E., FRIEDBERG, T., and OESCH, F., 1985, Regulation and expression of four cytochrome P-450 isoenzymes, NADPH-cytochrome P-450 reductase, the glutathione transferase B and C and microsomal epoxide hydrolase in preneoplastic lesions in rat liver. Carcinogenesis, 6, 513–521.
  • CARR, B. I., and LAISHES, B. A., 1981, Carcinogen-induced drug resistance in rat hepatocytes. Cancer Research, 41, 1715–1719.
  • COHEN, M. B., HABER, M. M., HOLLY, E. A., AHN, D. K., BormEs, K., and STOLOFF, A., 1991, Cytologic criteria to distinguish hepatocellular carcinoma from nonneoplastic liver. American Journal of Clinical Pathology, 95, 125–130.
  • CORDELL, J. L., FALINI, B., ERBER, W .N., GHosti, A. K., ABOULAZIZ, M., MACDONALD, S., PULFORD, K. A. F., STEIN, M., and MASON, D. Y., 1984, Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). Journal of Histochemistry and Cytochemistry, 32, 219–229.
  • DEPIERRE, J. W., MEIJER, J., BIRBERG, W., PILOTTI, A., BALK, L., and SEIDEGARD, J., 1983, Microsomal and cytosolic epoxide hydrolases: total activities, subcellular distribution and induction in the liver and extrahepatic tissues. In: Extrahepatic Drug Metabolism and Chemical Carcinogenesis. Edited by: J. Rydström and M. Mentehusiand, Mbenatsson (Elsevier), pp. 95–103.
  • DEWAZIERS, I., CUGNENC, P. H., YANG, C. S., LEROUX, J. P., and BEAUNE, P. H., 1990, Cytochrome P450 isoenzyme, epoxide hydrolase and glutathione S-transferases in rat and human hepatic and extrahepatic tissue. Journal of Pharmacology and Experimental Therapeutics, 253, 387–394.
  • DIPPLE, A., SAWICKI, J. T., MOSCHEL, R. C., AND BIGGER, C. A. H., 1983, 7, 12- Dimethyl-benz[a]anthracene-DNA interactions in mouse embryo cell cultures and mouse skin. In: Extrahepatic Drug Metabolism and Chemical Carcinogenesis. Edited by: J. Rydström and M. Mentehusiand, Mbenatsson (Elsevier), pp. 441–447.
  • FAIRCHILD, C. R., IVY, S. P., RUSHMORE, T., LEE, G., Koo, P., GOLDSMITH, M. E., MyEas, C., FARBE.'12, E., and COWAN, K. H., 1987, Carcinogen-induced mdr overexpression is associated with xenobiotic resistance in rat preneoplastic liver nodules and hepatocellular carcinomas. Proceedings of the National Academy of Sciences, USA, 84, 7701–7705.
  • FRITZ, P., BEHRLE, E., BEAUNE, P., EICHELBAUM, M., and KROMER, H. K., 1993, Differential expression of drug metabolizing enzymes in primary and secondary liver neoplasm: immunohistochemical characterization of cytochrome P4503A and glutathione S-transferase. Histochemistry, 99, 443–451.
  • FRITZ, P., MUELLER, J., WEGNER, G., BRAUN, U., GRAU, A., TUCZEK., H. V., MOESSNER, E., and SCHENK, R., 1985, Immunhistochemie: Theoretische Möglichkeiten, praktische Anwendungen. Zentralbl AlIg Pathol Pathol Anat, 130, 187–193.
  • FRITZ, P., TUCZEK, H. V., &FINGER, B., SCHW.ARZMANN, P., SCHIESZL, S., Wu, X., KLEINE, B., BLönoRN, J., and MULTHAUPT, H., 1992, Immunohistochemical quant;fication of steroid receptors and other prognosis factors in human breast cancer patients. Journal of Histochemistry and Cytochemistry, 26,146–158.
  • GAEDIGK, A., SPIEI.BERG, S. P., and GRANT, D. M., 1994, Characterization of the microsomal epoxide hydrolase gene in patients with anticonvulsant adverse drug reactions. Pharmacogenetics, 4, 142–153.
  • GERMER, H., BENTLEY, P., STAUBLI, W., and WAcHTER, F., 1989, Immunhistochemische Lokalisation von Epoxidhydrolasen in verschiedenen Organen von unbehandelten und mit Nafenopin behandelten DBA/2-Mäusen. Acta Histochemica, 37 (suppl.), 199–201.
  • GRANT, D. F., STORMS, D. H., and HAMMOCK, B. D., 1993, Molecular cloning and expression of murine liver soluble epoxide hydrolase. Journal of Biological Chemistry, 268, 17268–17633.
  • GUENGERICH, F. P., and TURVEY, C. G., 1991, Comparisons of levels of several microsomal cytochrome P-450 enzymes and epoxide hydrolase in normal and disease states using immunochemicaI analysis of surgical liver samples. Journal of Pharmacology and Experimental Therapeutics, 256, 1189–1194.
  • HALARNKAR, P. P., WIXTRON, R. N., SILVA, M. H., and HAMMOCK, B. D., 1989, Catabolism of epoxy fatty esters by the purified epoxide hydrolase from mouse and human liver. Archives in Biochemistry and Biophysics, 272, 226–236.
  • HOUN, H. Y., SANDERS, M. M., WALKER, E. M., and PAPPAS, A. A., 1991, Fine needle aspiration in the diagnosis of liver neoplastnas: a review. Annals of Clinical Laboratory Science, 21, 2–11.
  • HSU, S. M., RAINE, L., and FANGER, H., 1981, The use of anti-avidin antibody and avidin-biotin-complex in immunoperoxidase technics. American Journal of Clinical Pathology, 75, 816–821.
  • JANOT, F., PARISE, D., GOUYETTE, A., and CHABOT, G. G., 1993, Principal xenobiotic-metabolizing enzyme systems in human neck and squamous cell carcinoma. Carcinogenesis, 14,1279–1283.
  • JOHNSON, D. E., HERNDIER, B. G., MEDE1ROS, L. J., WARNKE, R. A., and ROUSE, R. V., 1988, The diagnostic utility of the keratin profiles of hepatocellular carcinoma and cholangiocarcinoma. American Journal of Surgical Pathology, 12, 187–197.
  • KAWABATA, T., GUE.NGERICH, F. P., and BARON, J., 1981, An immunohistochemical study on the localization and distribution of epoxide hydrolase within livers of untreated rats. Molecular Pharmacology, 20, 709–714.
  • KONDO, S., GERTSON, P. N., YOKOYAMA, K., and ITAKURA, K., 1994, Hepatic transcriptional up-regulation of the rat microsomal epoxide hydrolase gene. DNA Cell Biology 13, 43–50.
  • LEVIN, W., MICHAUD, D. P., THOMAS, P. E., and JERINA, D. M., 1983, Distinct rat hepatic microsomal epoxide hydrolases catalyze the hydration of cholesterol-5,6-alpha oxide and certain xenobiotic alkene and arene oxides. Archives in Biochemistry and Biophysics, 220, 485–494.
  • Lu, A. Y. H., and McwA, G. T., 1980, Molecular properties and biological functions of microsomal epoxide hydrolase. Annual Reviews in Pharmacology and Toxicology, 20,513–531.
  • MA, C. K., ZARB°, R. J,, FRIERSON, H. F., and LEE, M. W., 1993, Comparative immunohistochemical study of primary and metastatic carcinomas of the liver. American Journal of Clinical Pathology, 99, 551–557.
  • McGADEY, J., 1970, A tetrazolium method for non-specific alkaline phosphatase. Histochemie, 23, 180–184,
  • McKAY, J. A., MURRAY, G. I., WEAVER, R. J., EWEN, S. W., MELVIN, W. T., and BURKE, M. D., 1993, Xenobiotic metabolising enzyme expression in colonic neoplasia. Gut, 34, 1234–1239.
  • MEIJER, J., BIRBERG, W., PILOTTI, A., and DEPIERRE, J. W., 1983, Subcellular distribution of epoxide hydrolase activity in the liver, lung, kidney and testis of the C57 B1 male mouse. In: Extrahepatic Drug Metabolism and Chemical Carcinogeilesis. Edited by: J. Rydström and M. rvIentehusiand, Mbenatsson (Elsevier), pp. 221–222.
  • MOODY, D. E., LOURY, D. N., HAMMOCK, B. D., RuEBNER, B. H., CULLEN, J. H., HILLMAN, D. W., RAO, M. S., LONDON, W. T., and HANN, H. W., 1992, Serum epoxide hydrolase (preneoplastic antigen) in human and experimental liver injury. Cancer Epidemiology Biomarkers Preview, 1, 395–405.
  • MURRAY, G. I., BARNES, T. S., SEWELL, H. F., EWEN, S. W., MELVIN, W. T., and BURKE, M. D., 1988, The immunocytochemical localisation and distribution of cytochrome P450 in normal human hepatic and extrahepatic tissues with a monoclonal antibody to human cytochrome P450. British Journal of Clinical Pharmacology, 25,465–475.
  • MURRAY, G. I., P.ATERSON, P. J., WEAVER, R. J., EV4'EN, S. W., MELVIN, W. T., and BURKE, M. D., 1993, The expression of cytochrome P-450, epoxide hydrolase and gIutathion S-transferase in hepatocellular carcinoma. Cancer, 71,36–43.
  • MURRAY, G. J., WEAVER, R. J., PATERSON, P. J., EWEN, S. W., MELVIN, W. T., and BURKE, M. D., 1993, Expression of xenobiotic metabolizing enzymes in breast cancer. Journal of Pathology, 169, 347–353.
  • OMIECINSKI, C. J., AlcHER, L., and SWENSON, L., 1993, Developmental expression of human microsomal epoxide hydrolase. Journal of Pharmacology and Experimental Therapeutics, 269, 417–423.
  • PACIFICI, G. M., and RANE, A., 1983, Profile of drug metabolizing enzymes in the nuclei and microsomes of hepatic and extrahepatic tissue from monkeys. In: Extrahepatic Drug Metabolism and Chemical Carcinogenesis. Edited by: J. Rydström and M. Mentehusiand Mbenatsson (Elsevier), pp. 33–37.
  • PHILIP, P. A., KAKLAMANIS, L., RYLEY, N., WoLE, R., HARRIS, A., and CARMICHAEL, J., 1994, Expression of xenobiotic-metabolizing enzymes by primary and secondary hepatic tumors in man. International Journal of Radiation Oncology, Biology, Physics, 29, 277–283.
  • RATANASAVANH, D., BEAUNE, P., MOREL, F., FILINOIS, J. P., GUENGERICH, F. P., and GUILLOUZO, A., 1991, Intralobular distribution and quantitation of c,ytochrome P-450 enzymes in human liver as function of age. Hepatology, 13, 1142–1151.
  • SCHWARZMANN, P., 1994, Bildauswertung in der Pathologic. Pra.viscomputer, 6, 48–51.
  • SCHWARZMANN, P., Wu, X., FRITZ, P., and TUCZEK, H. V., 1994, Histoanal,yzer: a device for computer-assisted pathology. Annals of Quant Cytol Histol, 16, 71–72.
  • SEIDEGARD, J., and DE PIERRE, J. W., 1983, Microsomal epoxide hydrolase. Properties, regulation and function. Biochimica et Biophysica Acta, 695, 251–270.
  • SKODA, R. C., DEMIERRE, A., McBRIDE, O. W., GONZALEZ, F. J., and MEYER, U. A., 1988, Human microsomal xenobiotic epoxide hydrolase. Complementary DNA sequence, complementary DNA-directed expression in COS-1 cells, and chromosomal localization. Journal of Biological Chemistry, 263, 1549–1554.
  • SNYDER, R., CHEPIGA, T., YANG, C. S., THOMAS, IL, PLATT, K., and OESCH, F., 1993, Benzene metabolism by reconstituted cytochromes P450, 2B1 and 2E1 and its modulation by cytochrome microsomal epoxide hydrolase and glutathione transferases: evidence for an important role of microsomal epoxide hydrolase in the formation of hydroquinone. Toxicology and Applied Pharmacology, 122, 172–181.
  • STERNBERGER, L. A., HARDY, P. H., Cuctims, J. J., and MEYER, H. G., 1970, The unlabeled antibody enzyme method of immunohistochemistry. Preparation and properties of soluble antigen-antibody complex (horseradish peroxidase-antihoresradish peroxidase) and its use in identification of spirochaetes. Journal of Histochemistry and Cytochemistry, 18, 315–334.
  • THEISE, N. O., 1994, Distinguishing primary and metastatic carcinomas of the liver: immuno-histochemical updates and reminders. Hepatology, 19, 1313–1315.
  • THOMAS, H., SCHLADT, L., DOEHMER, J., KNEHR, M., and OESCH F., 1990, Rat and human liver cytosolic epoxide hydrolases. Evidence for multiple forms at level of protein and mRNA. Environmental Health Perspectives, 88, 49–55.
  • TOUSSAINT, C., ALBIN, N., MASSAAD, L., GRUNEWALD, D., PARISE, O., MORIZET, J., GOUYETTE, A., and CHABOT, G. G., 1993, Main drug- and carcinogen-metabolizing enzyme systems in human non-small cell lung cancer and peritumoral tissues. Cancer Research, 53, 4608–4612.
  • VANEYKEN, P., SCIOT, R., PATERSON, A., CALLEA, F., KEW, M. C., and DESMET, V. J., 1988, Cytokeration expression in hepatocellular carcinoma: an immunohistochemical study. Human Pathology, 19, 562–568.
  • WILSON, N.M., and OMIECINSKI, C. J., 1989, Xenobiotic microsomal epoxide hydrolase: 5' sequence of the human gene. Biochimica et Biophysica Acta, 1008, 357–358.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.